Finance1 min read

Sanofi Consumer share price jumps 11% after strong Q3 results | Is it time to book profits? Check target, rationale

By · Published by Everything Blog

In short

The company saw its consolidated profit advance 22.2% year-on-year to ₹77 crore as operational revenue climbed 12.4% to reach ₹263 crore. Operating efficiency improved simultaneously, driving EBITDA up to ₹102 crore with margins expanding to 38.7% despite an uptick in total quarterly expenses to ₹164.8 crore. Over the nine-month period ending in September, combined strength in domestic sales and exports lifted revenue 16% to ₹728 crore.

Key points

  • Sanofi Consumer Healthcare India gained up to 11% to reach an intraday high of ₹3,771.90…: Sanofi Consumer Healthcare India gained up to 11% to reach an intraday high of ₹3,771.90 on the NSE.
  • Nine-month operations generated ₹728 crore in revenue, supported by a 19% increase in exp…: Nine-month operations generated ₹728 crore in revenue, supported by a 19% increase in export activity.
  • The stock remains down 24.60% year-to-date and 26.38% over the past year despite this qua…: The stock remains down 24.60% year-to-date and 26.38% over the past year despite this quarterly earnings rebound.

Sources checked by our analysis pipeline: 1

Sanofi Consumer Healthcare share price surged as much as 11% in Thursday's trading session after the company reported strong set of numbers during the September quarter FY27.

Sanofi Consumer shares opened at ₹3,502.20 on NSE today, as compared to previous close of ₹3,322.80 on Wednesday and touched an intraday high of ₹3,771.90 on 29 October.

Sanofi Consumer Healthcare India reported a 22.2% year-on-year rise in consolidated profit to ₹77 crore in the September quarter of calendar year 2026, compared with ₹63 crore in the corresponding period last year.

Revenue from operations increased 12.4% year-on-year to ₹263 crore from ₹234 crore. EBITDA rose to ₹102 crore from ₹85 crore, while the EBITDA margin improved to 38.7% from 36.4%. Meanwhile, total expenses climbed to ₹164.8 crore from ₹152.8 crore in the year-ago quarter.

The company reported 19% year-on-year growth in domestic sales. For the nine months ended September 2026, revenue from operations grew 16% to ₹728 crore from ₹627.4 crore in the corresponding period last year. Domestic sales increased 15%, supported by product relaunches, while exports recorded 19% growth.

Commenting on the…

Finance